sygnaturediscovery.com

Revisión web de sygnaturediscovery.com

Sygnature Discovery - Leading Contract Research Organisation

 Generado el 06 Abril 2026 22:57 PM

Resultados antiguos? ACTUALIZAR !

La puntuación es 63/100

Contenido SEO

Título

Sygnature Discovery - Leading Contract Research Organisation

Longitud : 60

Perfecto, tu título contiene entre 10 y 70 caracteres.

Descripción

Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).

Longitud : 133

Genial, tu descripción meta contiene entre 70 y 160 caracteres.

Palabras Claves (Keywords)

Muy mal. No hemos encontrado palabras clave (meta keywords) en tu página. Usa este generador de meta tags gratuito para crear tus palabras clave.

Propiedades Meta Og

Bien. Tu página usa propiedades Og (etiquetas og).

Propiedad Contenido
locale en_US
type website
title Sygnature Discovery - Leading Contract Research Organisation
description Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).
url https://www.sygnaturediscovery.com/
site_name Sygnature
image https://www.sygnaturediscovery.com/wp-content/uploads/2026/02/sygnature-hit-to-lead-team-collaboration-scaled.webp
image:width 2560
image:height 1707
image:type image/webp

Titulos

H1 H2 H3 H4 H5 H6
1 25 28 137 8 0
  • [H1] Achieving exceptional scientific outcomesthrough connected drug discovery.
  • [H2] World-leading drug discovery solutions, accelerating your compound to the clinic.
  • [H2] We offer deep expertise across the full range of drug discovery solutions.
  • [H2] We deliver world-class scientific expertise and flexible services across every discipline in preclinical discovery.
  • [H2] Integrated Drug Discovery
  • [H2] Computer Aided Drug Design
  • [H2] Protein & Structure
  • [H2] Bioscience
  • [H2] Chemistry
  • [H2] Drug Metabolism and Pharmacokinetics (DMPK)
  • [H2] in vivo Pharmacology
  • [H2] Form and Formulation
  • [H2] We offer specialist expertise across a range of modalities, target classes and therapeutic areas.
  • [H2] Modalities
  • [H2] Target Classes
  • [H2] Therapeutic Areas
  • [H2] World-leading drug discovery
  • [H2] At Sygnature Discovery, we create exceptional scientific outcomes
  • [H2] Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America
  • [H2] Impact that lasts
  • [H2] Our track record
  • [H2] Trusted by customers worldwide
  • [H2] Interested in joining our team?
  • [H2] News & Resources
  • [H2] Ready to start a conversation?
  • [H2] You're in the right place!
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources Overview
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] From Lead to Pre-Candidate Nomination in 18 Months
  • [H3] Sitryx: Empowering New Ideas
  • [H3] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H3] Corcept Therapeutics: Integrated Drug Discovery Collaboration
  • [H3] CellCentric Lead Optimisation Campaign – CCS1477
  • [H3] Fragment-based hit discovery for the epigenetic target, BRD3
  • [H3] Hit Identification to 3 Compounds in the Clinic and 6 Development Candidates
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Computer Aided Drug Design
  • [H4] Bioinformatics
  • [H4] Target Analysis
  • [H4] Virtual Screening
  • [H4] Structure Based Drug Design
  • [H4] Generative AI and Machine Learning
  • [H4] Ligand Based Drug Design
  • [H4] Library Design
  • [H4] ADMET Predictions
  • [H4] Informatics
  • [H4] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H4] Protein Science and Structural Biology
  • [H4] Protein Expression and Purification
  • [H4] Membrane Proteins
  • [H4] Antibodies and Biotherapeutics
  • [H4] Structural Biology
  • [H4] X-Ray Crystallography
  • [H4] cryo-EM
  • [H4] Macromolecular NMR
  • [H4] Protein Characterization
  • [H4] Protein Mass Spectrometry
  • [H4] FIDA
  • [H4] A Comparison of the Structural Techniques used at Sygnature Discovery: X-ray Crystallography, NMR and Cryo-EM
  • [H4] Bioscience
  • [H4] Cell Line Generation
  • [H4] Assay Development
  • [H4] Electrophysiology
  • [H4] High Throughput Screening
  • [H4] Cell Based Assays
  • [H4] Biochemical Assays
  • [H4] Biophysical Assays
  • [H4] Primary Cells and Tissues
  • [H4] Integrating Hit Finding and Direct-to-Biology to Shorten Time to Development Candidate
  • [H4] Chemistry
  • [H4] Medicinal Chemistry
  • [H4] Synthetic Chemistry
  • [H4] Process & Scale-up Chemistry
  • [H4] NMR-Spectroscopy
  • [H4] Separation Sciences
  • [H4] High Throughput Chemistry
  • [H4] Why Early Process Chemistry Matters?
  • [H4] Drug Metabolism and Pharmacokinetics
  • [H4] Physicochemical Profiling
  • [H4] Chemical & Metabolic Stability
  • [H4] Permeability
  • [H4] Tissue Binding
  • [H4] Drug-Drug Interactions
  • [H4] Biotransformation
  • [H4] Analytical Method Development & Bioanalysis
  • [H4] in vivo Pharmacokinetic & Pharmacodynamic Studies
  • [H4] PK & PK/PD Modelling and Simulation
  • [H4] DMPK Consultancy
  • [H4] Dedicated DMPK for Bifunctional Degraders: A Flexible Approach for Flexible Molecules
  • [H4] in vivo Pharmacology
  • [H4] CNS/Pain Models
  • [H4] Metabolic Disease Models
  • [H4] Inflammation & Immunology Models
  • [H4] Oncology Models
  • [H4] Non-Regulatory Toxicology
  • [H4] in vivo Pharmacokinetics
  • [H4] ex vivo Tissue Analysis
  • [H4] Evaluation of Two Novel Compounds Compared to Methadone on Morphine Withdrawal in a Rat Model of Physical dependence
  • [H4] Form & Formulation
  • [H4] Early Clinical Formulation
  • [H4] Solid Form Analysis
  • [H4] Salt and Co-Crystal Screening
  • [H4] Polymorph Screening
  • [H4] Pre-Clinical Formulation
  • [H4] Assessing Lypoprotectant Effect on Particle Size of Liposomal Systems
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Ion Channels
  • [H4] GABAA Receptors
  • [H4] NMDA Receptors
  • [H4] Glycine Receptors
  • [H4] Nicotinic Receptors
  • [H4] TRP Channels
  • [H4] Sodium Channels
  • [H4] Calcium Channels
  • [H4] Potassium Channels
  • [H4] Chloride Channels
  • [H4] TMEM175
  • [H4] Delivering Custom Cell-Based Tools for Drug Discovery
  • [H4] Sygnature Discovery Successfully Provides Clinical Candidate to Corcept Therapeutics
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] Blog
  • [H4] Webinars & Podcasts
  • [H4] Posters
  • [H4] Journal Papers
  • [H4] Technical Notes
  • [H4] Case Studies
  • [H4] eBooks
  • [H4] Protocols
  • [H4] News
  • [H4] Events
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] UK (Nottingham)
  • [H5] Our Office Locations
  • [H5] Drug Discovery
  • [H5] modalities
  • [H5] Target Classes
  • [H5] Scientific solutions
  • [H5] Therapeutic Areas
  • [H5] Website
  • [H5] Resource Hub

Imagenes

Hemos encontrado 77 imágenes en esta web.

38 atributos alt están vacios o no existen. Agrega texto alternativo para que los motores de búsqueda puedan entender las imágenes.

Ratio Texto/HTML

Ratio : 26%

Ideal! El ratio entre texto y código HTML de esta página está entre 25 y 70 por ciento.

Flash

Perfecto, no se ha detectado contenido Flash en la página.

Iframe

Muy mal, tienes Iframes en la página, esto significa que el contenido no podrá ser indexado.

Reescritura URL

Bien. Tus enlaces parecen amigables

Guiones bajos en las URLs

Hemos detectado guiones bajos en tus URLs. Deberías usar guiones en su lugar para optimizar tu SEO.

Enlaces en página

Hemos encontrado un total de 70 enlaces incluyendo 4 enlace(s) a ficheros

Ancla Tipo Jugo
Explore the STORM Therapeutics case study Interna Pasando Jugo
Contact Interna Pasando Jugo
Contact us Interna Pasando Jugo
Get in touch Interna Pasando Jugo
What we do Interna Pasando Jugo
Learn more about Drug Discovery Interna Pasando Jugo
Learn more about Scientific Solutions Interna Pasando Jugo
Explore CADD Interna Pasando Jugo
Explore Protein and Structure Interna Pasando Jugo
Explore Bioscience Interna Pasando Jugo
Explore Chemistry Interna Pasando Jugo
Explore DMPK Interna Pasando Jugo
Explore in vivo Pharmacology Interna Pasando Jugo
Explore Form and Formulation Interna Pasando Jugo
Discover our Modalities Interna Pasando Jugo
Learn more about Target Classes Interna Pasando Jugo
Explore our Therapeutic Areas Interna Pasando Jugo
At Sygnature Discovery, we create exceptional scientific outcomes Interna Pasando Jugo
Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America Interna Pasando Jugo
Impact that lasts Interna Pasando Jugo
Learn more Interna Pasando Jugo
Read the case study Interna Pasando Jugo
Read the case study Interna Pasando Jugo
Read the case study Interna Pasando Jugo
Read the case study Interna Pasando Jugo
Read the case study Interna Pasando Jugo
Read the case study Interna Pasando Jugo
View our Careers Page Interna Pasando Jugo
Bringing Connected Drug Discovery Together Under One Name Interna Pasando Jugo
Dr Simon Hirst awarded prestigious honorary Doctorate from the University of Nottingham Interna Pasando Jugo
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment Interna Pasando Jugo
Sygnature Discovery boosts growth of its in vivo Pharmacology business with appointment of new Vice President Interna Pasando Jugo
Sygnature Discovery Appoints New Chief Commercial Officer to Drive Next Phase of Business Growth Interna Pasando Jugo
Sygnature Discovery appoints Rick Davies to spearhead growth as Director of its UK Protein Sciences and Structural Biology business (formerly, Peak Proteins) Interna Pasando Jugo
View all locations Interna Pasando Jugo
Target Identification & Validation Interna Pasando Jugo
Hit Identification Interna Pasando Jugo
Hit-to-Lead Interna Pasando Jugo
Lead Optimization Interna Pasando Jugo
Small Molecules Interna Pasando Jugo
Peptides Interna Pasando Jugo
Targeted Protein Degradation Interna Pasando Jugo
ADCs Interna Pasando Jugo
Biologics Interna Pasando Jugo
Ion channels Interna Pasando Jugo
GPCRs Interna Pasando Jugo
Transporters Interna Pasando Jugo
Oncology Interna Pasando Jugo
Inflammation and Immunology Interna Pasando Jugo
Neuroscience Interna Pasando Jugo
Metabolic Diseases Interna Pasando Jugo
Meet our Team Interna Pasando Jugo
Working with us Interna Pasando Jugo
Environmental, social, governance Interna Pasando Jugo
Blog Interna Pasando Jugo
Webinars & Podcasts Interna Pasando Jugo
Posters Interna Pasando Jugo
Journal Papers Interna Pasando Jugo
Technical Notes Interna Pasando Jugo
eBooks Interna Pasando Jugo
Protocols Interna Pasando Jugo
Case Studies Interna Pasando Jugo
News Interna Pasando Jugo
Events Interna Pasando Jugo
Privacy Policy Interna Pasando Jugo
Cookie Policy Interna Pasando Jugo
Website terms of use Interna Pasando Jugo
Modern Slavery Statement Interna Pasando Jugo
Supplier Code of Conduct Interna Pasando Jugo
Website Design Agency Externo Pasando Jugo

Palabras Clave SEO

Nube de Palabras Clave

discovery integrated design expertise drug target solutions chemistry sygnature from

Consistencia de las Palabras Clave

Palabra Clave (Keyword) Contenido Título Palabras Claves (Keywords) Descripción Titulos
discovery 91
drug 68
sygnature 33
integrated 26
expertise 25

Usabilidad

Url

Dominio : sygnaturediscovery.com

Longitud : 22

Favicon

Genial, tu web tiene un favicon.

Imprimibilidad

Genial. Hemos encontrado una hoja de estilos CSS para impresión.

Idioma

Genial. Has declarado el idioma en.

Dublin Core

Esta página no usa Dublin Core.

Documento

Tipo de documento (Doctype)

HTML 5

Codificación

Perfecto. Has declarado como codificación UTF-8.

Validez W3C

Errores : 0

Avisos : 0

Privacidad de los Emails

Atención! Hemos encontrado por lo menos una dirección de correo electrónico en texto plano. Usa este protector antispam gratuito para ocultarla de los spammers.

HTML obsoleto

Genial, no hemos detectado ninguna etiqueta HTML obsoleta.

Consejos de Velocidad

Excelente, esta web no usa tablas.
Muy mal, tu web está usando estilos embenidos (inline CSS).
Muy mal, tu página web usa demasiados ficheros CSS (más de 4).
Muy mal, tu sitio usa demasiados ficheros JavaScript (más de 6).
Su sitio web se beneficia del tipo de compresión gzip. ¡Perfecto!

Movil

Optimización Móvil

Icono para Apple
Etiqueta Meta Viewport
Contenido Flash

Optimización

Mapa del sitio XML

¡Perfecto! Su sitio tiene un mapa del sitio en XML.

https://www.sygnaturediscovery.com/sitemap_index.xml

Robots.txt

https://sygnaturediscovery.com/robots.txt

¡Estupendo! Su sitio web tiene un archivo robots.txt.

Herramientas de Analítica

No disponible

No hemos encontrado ninguna herramienta de analítica en esta web.

La analítica Web le permite medir la actividad de los visitantes de su sitio web. Debería tener instalada al menos una herramienta de analítica y se recomienda instalar otra más para obtener una confirmación de los resultados.

PageSpeed Insights

Dispositivo
Categorias

Free SEO Testing Tool

Free SEO Testing Tool es una herramienta seo gratuita que te ayuda a analizar tu web